Reverse Engineering Provides Insights on the Evolution of Subgroups A to E Avian Sarcoma and Leukosis Virus Receptor Specificity †

por Federspiel, Mark J.
Publicado 2019

Avian Sarcoma and Leukosis Virus Envelope Glycoproteins Evolve to Broaden Receptor Usage Under Pressure from Entry Competitors †

por Munguia, Audelia, Federspiel, Mark J.
Publicado 2019

Recombinant mumps virus as a cancer therapeutic agent

por Ammayappan, Arun, Russell, Stephen J, Federspiel, Mark J
Publicado 2016

Mutations in Both the Surface and Transmembrane Envelope Glycoproteins of the RAV-2 Subgroup B Avian Sarcoma and Leukosis Virus Are Required to Escape the Antiviral Effect of a Sec...

por Yin, Xueqian, Melder, Deborah C., Payne, William S., Dodgson, Jerry B., Federspiel, Mark J.
Publicado 2019

Polyinosinic acid decreases sequestration and improves systemic therapy of measles virus

por Liu, Yu-Ping, Tong, Caili, Dispenzieri, Angela, Federspiel, Mark J., Russell, Stephen J., Peng, Kah-Whye
Publicado 2011

Curative one-shot systemic virotherapy in murine myeloma

por Naik, Shruthi, Nace, Rebecca, Federspiel, Mark J., Barber, Glen N., Peng, Kah-Whye, Russell, Stephen J.
Publicado 2012

Pinhole Micro-SPECT/CT for Noninvasive Monitoring and Quantitation of Oncolytic Virus Dispersion and Percent Infection in Solid Tumors

por Penheiter, Alan R., Griesmann, Guy E., Federspiel, Mark J., Dingli, David, Russell, Stephen J., Carlson, Stephanie K.
Publicado 2011

Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV

por Yarde, Danielle N., Naik, Shruthi, Nace, Rebecca A., Peng, Kah-Whye, Federspiel, Mark J., Russell, Stephen J.
Publicado 2013

Progress in Gene Therapy for Prostate Cancer

por Ahmed, Kamran A., Davis, Brian J., Wilson, Torrence M., Wiseman, Gregory A., Federspiel, Mark J., Morris, John C.
Publicado 2012

Oncolytic measles virus strains have significant antitumor activity against glioma stem cells

por Allen, Cory, Opyrchal, Mateusz, Aderca, Ileana, Schroeder, Mark A., Sarkaria, Jann N., Domingo, Evidio, Federspiel, Mark J., Galanis, Evanthia
Publicado 2012

Live Attenuated Measles Virus Vaccine Expressing Helicobacterpylori Heat Shock Protein A

por Iankov, Ianko D., Kurokawa, Cheyne, Viker, Kimberly, Robinson, Steven I., Ammayappan, Arun, Panagioti, Eleni, Federspiel, Mark J., Galanis, Evanthia
Publicado 2020

Mathematical Model for Radial Expansion and Conflation of Intratumoral Infectious Centers Predicts Curative Oncolytic Virotherapy Parameters

por Bailey, Kent, Kirk, Amber, Naik, Shruthi, Nace, Rebecca, Steele, Michael B., Suksanpaisan, Lukkana, Li, Xing, Federspiel, Mark J., Peng, Kah-Whye, Kirk, David, Russell, Stephen J.
Publicado 2013

Optimizing patient derived mesenchymal stem cells as virus carriers for a Phase I clinical trial in ovarian cancer

por Mader, Emily K, Butler, Greg, Dowdy, Sean C, Mariani, Andrea, Knutson, Keith L, Federspiel, Mark J, Russell, Stephen J, Galanis, Evanthia, Dietz, Allan B, Peng, Kah-Whye
Publicado 2013

Oncolytic Urabe mumps virus: A promising virotherapy for triple-negative breast cancer

por Behrens, Marshall D., Stiles, Robert J., Pike, Gennett M., Sikkink, Laura A., Zhuang, Yongxian, Yu, Jia, Wang, Liewei, Boughey, Judy C., Goetz, Matthew P., Federspiel, Mark J.
Publicado 2022

Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy

por Iankov, Ianko D., Kurokawa, Cheyne B., D’Assoro, Antonio B., Ingle, James N., Domingo-Musibay, Evidio, Allen, Cory, Crosby, Catherine M., Nair, Asha A., Liu, Minetta C., Aderca, Ileana, Federspiel, Mark J., Galanis, Evanthia
Publicado 2015

Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H.pylori immunostimulatory bacterial transgene

por Viker, Kimberly B., Steele, Michael B., Iankov, Ianko D., Concilio, Susanna C., Ammayappan, Arun, Bolon, Brad, Jenks, Nathan J., Goetz, Matthew P., Panagioti, Eleni, Federspiel, Mark J., Liu, Minetta C., Peng, Kah Whye, Galanis, Evanthia
Publicado 2022

Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer

por Patel, Manish R., Jacobson, Blake A., Ji, Yan, Drees, Jeremy, Tang, Shaogeng, Xiong, Kerry, Wang, Hengbing, Prigge, Jennifer E., Dash, Alexander S., Kratzke, Andrea K., Mesev, Emily, Etchison, Ryan, Federspiel, Mark J., Russell, Stephen J., Kratzke, Robert A.
Publicado 2015

Phase I Trial of Systemic Administration of Edmonston Strain of Measles Virus, Genetically Engineered to Express the Sodium Iodide Symporter in Patients with Recurrent or Refractor...

por Dispenzieri, Angela, Tong, Caili, LaPlant, Betsy, Lacy, Martha Q., Laumann, Kristina, Dingli, David, Zhou, Yumei, Federspiel, Mark J., Gertz, Morie A., Hayman, Suzanne, Buadi, Francis, O’Connor, Michael, Lowe, Val J., Peng, Kah-Whye, Russell, Stephen J.
Publicado 2017

A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in u...

por Smith, Katherine E. R., Peng, Kah-Whye, Pulido, Jose S., Weisbrod, Adam J., Strand, Carrie A., Allred, Jacob B., Newsom, Alysha N., Zhang, Lianwen, Packiriswamy, Nandakumar, Kottke, Timothy, Tonne, Jason M., Moore, Madelyn, Montane, Heather N., Kottschade, Lisa A., McWilliams, Robert R., Dudek, Arkadiusz Z., Yan, Yiyi, Dimou, Anastasios, Markovic, Svetomir N., Federspiel, Mark J., Vile, Richard G., Dronca, Roxana S., Block, Matthew S.
Publicado 2023